tadalafil has been researched along with Recrudescence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabrini, MR; Nardozza, A | 1 |
| Chatterjee, S; Russell, A; Seed, M | 1 |
| Beslać-Bumbaširević, L; Ercegovac, MD; Jovanović, DR; Stefanović-Budimkić, M | 1 |
| Bollinger, K; Lee, MS | 1 |
| Harries, PG; Ismail, H | 1 |
| Bivalacqua, TJ; Burnett, AL; Champion, HC; Musicki, B | 1 |
6 other study(ies) available for tadalafil and Recrudescence
| Article | Year |
|---|---|
Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism.
Topics: Adult; Cyclic Nucleotide Phosphodiesterases, Type 5; Follow-Up Studies; Humans; Male; Phosphodiesterase 5 Inhibitors; Priapism; Prospective Studies; Recurrence; Secondary Prevention; Tadalafil; Young Adult | 2017 |
Does this case hold the answer to one of the worse types of pain in medicine--that of loin pain haematuria syndrome (LPHS).
Topics: Adult; Analgesics, Opioid; Drug Administration Schedule; Female; Hematuria; Humans; Pain, Intractable; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Ramipril; Recurrence; Syndrome; Tadalafil; Treatment Outcome; Ureter | 2015 |
Recurrent ischemic stroke associated with sildenafil and tadalafil use in a young adult.
Topics: Brain; Brain Ischemia; Carbolines; Coitus; Headache; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paresis; Piperazines; Purines; Recurrence; Sildenafil Citrate; Smoking; Stroke; Sulfones; Tadalafil; Vasodilator Agents | 2012 |
Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge.
Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Male; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Recurrence; Tadalafil; Visual Fields | 2005 |
Recurrent epistaxis after treatment with tadalafil (Cialis).
Topics: Aged; Carbolines; Epistaxis; Humans; Male; Phosphodiesterase Inhibitors; Recurrence; Tadalafil | 2005 |
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Anemia, Sickle Cell; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Nitric Oxide; Penile Erection; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Priapism; Purines; Recurrence; Signal Transduction; Sildenafil Citrate; Sulfones; Tadalafil | 2006 |